Benzinga | Nov 10, 2020 04:36PM EST

Clearside Biomedical Q3 EPS $(0.05) Beats $(0.12) Estimate, Sales $3.43M Beat $1.82M Estimate

Clearside Biomedical (NASDAQ:CLSD) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.12) by 58.33 percent. This is a 70.59 percent increase over losses of $(0.17) per share from the same period last year. The company reported quarterly sales of $3.43 million which beat the analyst consensus estimate of $1.82 million by 88.57 percent. This is a 2.33K percent increase over sales of $141.00 thousand the same period last year.